Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449499 · ClinicalTrials.gov registry record
Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 25
- Enrollment target
NCT02449499: Clinical Trial study, sponsored by Stanford University.
NCT02449499 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02449499 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Depression and anxiety disorders, even when treated according to standard of care consisting of individual treatment with medication and/or therapy, can be associated with significant residual impact on quality of life. The purpose of this research is carry out an observational study of an existing clinical treatment, adjunctive interpersonally focused psychodynamic group therapy, to determine if this can improve quality of life for patients who have residual symptoms of chronic depression and anxiety.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02449499
The ClinicalTrials.gov registry entry for NCT02449499 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02449499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02449499 about?
NCT02449499 is a clinical study titled "Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms". Depression and anxiety disorders, even when treated according to standard of care consisting of individual treatment with medication and/or therapy, can be associated with significant residual impact on quality of life. The purpose of this research is carry out an observational study of an existing ...
What is the current status of trial NCT02449499?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2015-04. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02449499?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.